Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Obstructive Lung Diseases

  Free Subscription


Articles published in Thorax

Retrieve available abstracts of 151 articles:
HTML format



Single Articles


    March 2024
  1. PETOUSI N, Pavord ID, Kent BD
    Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.
    Thorax. 2024;79:291-292.
    PubMed    


  2. CELIS-PRECIADO CA, Lachapelle P, Couillard S
    Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist.
    Thorax. 2024;79:297-298.
    PubMed    


  3. VOGIATZIS I
    Role of blood flow restriction strength training in chronic obstructive pulmonary disease.
    Thorax. 2024;79:289-290.
    PubMed    


  4. COLAK Y, Afzal S, Marott JL, Vestbo J, et al
    Type-2 inflammation and lung function decline in chronic airway disease in the general population.
    Thorax. 2024;79:349-358.
    PubMed     Abstract available


  5. KOHLBRENNER D, Kuhn M, Manettas A, Aregger C, et al
    Low-load blood flow restriction strength training in patients with COPD: a randomised single-blind pilot study.
    Thorax. 2024;79:340-348.
    PubMed     Abstract available


  6. WANG KCW, Blakey JD
    Impacts of sex and gender on severe asthma.
    Thorax. 2024 Mar 7:thorax-2023-221117. doi: 10.1136/thorax-2023-221117.
    PubMed    


  7. MORGAN AD
    Unravelling the obesity-asthma connection in childhood and adolescence: does body shape matter?
    Thorax. 2024 Mar 7:thorax-2023-221345. doi: 10.1136/thorax-2023-221345.
    PubMed    


    February 2024
  8. WILKINSON AJK, Maslova E, Janson C, Radhakrishnan V, et al
    Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study.
    Thorax. 2024 Feb 27:thorax-2023-220259. doi: 10.1136/thorax-2023-220259.
    PubMed     Abstract available


  9. KOUIS P, Galanakis E, Michaelidou E, Kinni P, et al
    Improved childhood asthma control after exposure reduction interventions for desert dust and anthropogenic air pollution: the MEDEA randomised controlled trial.
    Thorax. 2024 Feb 22:thorax-2023-220877. doi: 10.1136/thorax-2023-220877.
    PubMed     Abstract available


  10. JANSON C
    Does ICS treatment increase the risk of pneumonia in asthma?
    Thorax. 2024 Feb 22:thorax-2023-221360. doi: 10.1136/thorax-2023-221360.
    PubMed    


  11. GAY ACA, Banchero M, Carpaij O, Kole TM, et al
    Airway epithelial cell response to RSV is mostly impaired in goblet and multiciliated cells in asthma.
    Thorax. 2024 Feb 19:thorax-2023-220230. doi: 10.1136/thorax-2023-220230.
    PubMed     Abstract available


  12. PATEL K, Pye A, Edgar RG, Beadle H, et al
    Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD).
    Thorax. 2024;79:209-218.
    PubMed     Abstract available


  13. WHITTAKER H, Rothnie KJ, Quint JK
    Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England.
    Thorax. 2024;79:202-208.
    PubMed     Abstract available


  14. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Ten Hacken NHT, et al
    Airway smooth muscle and long-term clinical efficacy following bronchial thermoplasty in severe asthma.
    Thorax. 2024 Feb 12:thorax-2023-220967. doi: 10.1136/thorax-2023-220967.
    PubMed     Abstract available


  15. NG KL, Park J, Belcher E, Moore AJ, et al
    Not all wheeze is asthma.
    Thorax. 2024 Feb 7:thorax-2023-220953. doi: 10.1136/thorax-2023-220953.
    PubMed    


    January 2024
  16. BERTELS X, Lahousse L
    Understanding the aetiology of lung function impairment: the crucial role of age of onset.
    Thorax. 2024;79:106-107.
    PubMed    


  17. HALL I
    Tobacco use: a smoking gun for IPF?
    Thorax. 2024;79:104-105.
    PubMed    


  18. CARSIN AE, Garcia-Aymerich J, Accordini S, Dharmage S, et al
    Spirometric patterns in young and middle-aged adults: a 20-year European study.
    Thorax. 2024;79:153-162.
    PubMed     Abstract available


  19. SIELINOU KAMGANG KH, Rhedin SA, Almqvist C, Wintzell V, et al
    Use of inhaled corticosteroids and the risk of hospitalisation for pneumonia in children with asthma: a nationwide cohort study.
    Thorax. 2024 Jan 6:thorax-2023-220742. doi: 10.1136/thorax-2023-220742.
    PubMed     Abstract available


    December 2023
  20. HOOF I, Bonnelykke K, Stranzl T, Brand S, et al
    Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma.
    Thorax. 2023 Dec 30:thorax-2023-220707. doi: 10.1136/thorax-2023-220707.
    PubMed     Abstract available


  21. LOEWENTHAL L, Busby J, McDowell R, Brown T, et al
    Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care.
    Thorax. 2023 Dec 16:thorax-2023-220512. doi: 10.1136/thorax-2023-220512.
    PubMed     Abstract available


  22. XING Z, Yang T, Shi S, Meng X, et al
    Combined effect of ozone and household air pollution on COPD in people aged less than 50 years old.
    Thorax. 2023;79:35-42.
    PubMed     Abstract available


  23. TRIFIRO G, Crisafulli S
    Is antidepressant use a concern for patients with COPD?
    Thorax. 2023;79:3-4.
    PubMed    


  24. MIKI K, Tsujino K, Fukui M, Miki M, et al
    Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial.
    Thorax. 2023;79:23-34.
    PubMed     Abstract available


  25. HURT W, Youngs J, Ball J, Edgeworth J, et al
    COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
    Thorax. 2023;79:75-82.
    PubMed     Abstract available


  26. SIRAJ RA, Bolton CE, McKeever TM
    Association between antidepressants with pneumonia and exacerbation in patients with COPD: a self-controlled case series (SCCS).
    Thorax. 2023;79:50-57.
    PubMed     Abstract available


  27. BUSBY J, McDowell PJ, Pfeffer PE, Mansur AH, et al
    Ethnic variation in asthma phenotypic presentation and outcomes: a cross-sectional analysis of the UK Biobank.
    Thorax. 2023 Dec 7:thorax-2023-221101. doi: 10.1136/thorax-2023-221101.
    PubMed     Abstract available


  28. KHALAF Z, Bush A, Saglani S, Bloom CI, et al
    Influence of age on clinical characteristics, pharmacological management and exacerbations in children with asthma.
    Thorax. 2023 Dec 7:thorax-2023-220603. doi: 10.1136/thorax-2023-220603.
    PubMed     Abstract available



  29. Correction: Night shift work is associated with an increased risk of asthma.
    Thorax. 2023;78:e4.
    PubMed    


  30. SOUTO-MIRANDA S, Saraiva I, Spruit MA, Marques A, et al
    Core outcome set for pulmonary rehabilitation of patients with COPD: results of a modified Delphi survey.
    Thorax. 2023;78:1240-1247.
    PubMed     Abstract available


  31. BISGAARD H, Mikkelsen M, Rasmussen MA, Sevelsted A, et al
    Atopic and non-atopic effects of fish oil supplementation during pregnancy.
    Thorax. 2023;78:1168-1174.
    PubMed     Abstract available


    November 2023
  32. HAYES L, Mejia-Arangure JM, Errington A, Bramwell L, et al
    Relationship between air quality and asthma-related emergency hospital admissions in Mexico City 2017-2019.
    Thorax. 2023 Nov 8:thoraxjnl-2022-219262. doi: 10.1136/thorax-2022-219262.
    PubMed     Abstract available


  33. GERDAY S, Graff S, Moermans C, Guissard F, et al
    Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline.
    Thorax. 2023;78:1138-1141.
    PubMed     Abstract available


  34. ECHEVARRIA C, Steer J, Prasad A, Quint JK, et al
    Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD.
    Thorax. 2023;78:1090-1096.
    PubMed     Abstract available


    October 2023
  35. HANSEN H, Torre A, Kallemose T, Ulrik CS, et al
    Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation - a secondary responder analysis.
    Thorax. 2023;78:1039-1042.
    PubMed     Abstract available


  36. BUTTERY SC
    Getting the best from pulmonary rehabilitation.
    Thorax. 2023;78:951-952.
    PubMed    


  37. WARD TJ, Plumptre CD, Fraser-Pye AV, Dolmage TE, et al
    Understanding the effectiveness of different exercise training programme designs on V?O(2peak) in COPD: a component network meta-analysis.
    Thorax. 2023;78:1035-1038.
    PubMed     Abstract available


  38. BEMAND TJ, Chatoor R, Natale P, Strippoli G, et al
    Acetazolamide for metabolic alkalosis complicating respiratory failure with chronic obstructive pulmonary disease or obesity hypoventilation syndrome: a systematic review.
    Thorax. 2023;78:1004-1010.
    PubMed     Abstract available


  39. ROSS BA, Doiron D, Benedetti A, Aaron SD, et al
    Short-term air pollution exposure and exacerbation events in mild to moderate COPD: a case-crossover study within the CanCOLD cohort.
    Thorax. 2023;78:974-982.
    PubMed     Abstract available


  40. VERSTRAETE K, Gyselinck I, Huts H, Das N, et al
    Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials.
    Thorax. 2023;78:983-989.
    PubMed     Abstract available


  41. MAN W, Chaplin E, Daynes E, Drummond A, et al
    British Thoracic Society Clinical Statement on pulmonary rehabilitation.
    Thorax. 2023;78.
    PubMed    


  42. BOLTON CE
    Pulmonary rehabilitation marches on: refining, optimising and delivering through the clinical statement.
    Thorax. 2023;78.
    PubMed    


    September 2023

  43. Correction: Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data.
    Thorax. 2023;78:e3.
    PubMed    


  44. PATEL JH, Amaral AFS, Minelli C, Elfadaly FG, et al
    Chronic airflow obstruction attributable to poverty in the multinational Burden of Obstructive Lung Disease (BOLD) study.
    Thorax. 2023;78:942-945.
    PubMed     Abstract available


  45. KENDZERSKA T, Povitz M, Gershon AS, Ryan CM, et al
    Association of clinically significant obstructive sleep apnoea with risks of contracting COVID-19 and serious COVID-19 complications: a retrospective population-based study of health administrative data.
    Thorax. 2023;78:933-941.
    PubMed     Abstract available


  46. FINNEGAN SL, Browning M, Duff E, Harmer CJ, et al
    Brain activity measured by functional brain imaging predicts breathlessness improvement during pulmonary rehabilitation.
    Thorax. 2023;78:852-859.
    PubMed     Abstract available


  47. LENOIR A, Whittaker H, Gayle A, Jarvis D, et al
    Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data.
    Thorax. 2023;78:904-911.
    PubMed     Abstract available


    August 2023
  48. JACOB J
    Reimagining emphysema for a computational age.
    Thorax. 2023 Aug 17:thorax-2023-220458. doi: 10.1136/thorax-2023-220458.
    PubMed    


  49. WHITTAKER H, Nordon C, Rubino A, Morris T, et al
    Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study.
    Thorax. 2023;78:760-766.
    PubMed     Abstract available


    July 2023
  50. KALLIS C, Maslova E, Morgan AD, Sinha I, et al
    Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study.
    Thorax. 2023 Jul 31:thorax-2022-219757. doi: 10.1136/thorax-2022-219757.
    PubMed     Abstract available


  51. PEEL A, Wang R, Ahmed W, White I, et al
    Changes in exhaled volatile organic compounds following indirect bronchial challenge in suspected asthma.
    Thorax. 2023 Jul 26:thorax-2022-219708. doi: 10.1136/thorax-2022-219708.
    PubMed     Abstract available


  52. LEE SH, Kim J, Kim NH, Kim OH, et al
    Gut microbiota composition and metabolite profiling in smokers: a comparative study between emphysema and asymptomatic individuals with therapeutic implications.
    Thorax. 2023 Jul 26:thoraxjnl-2021-217923. doi: 10.1136/thorax-2021-217923.
    PubMed     Abstract available


  53. GIE A, Davies C, Vaida F, Morrison J, et al
    Lung function tracking in children with perinatally acquired HIV following early antiretroviral therapy initiation.
    Thorax. 2023 Jul 21:thorax-2023-220197. doi: 10.1136/thorax-2023-220197.
    PubMed     Abstract available


  54. KENYON S, Careless D, Navaratnam V, Reddy T, et al
    Rapidly progressive interstitial lung disease complicated by pulmonary interstitial emphysema in anti-MDA5 amyotrophic dermatomyositis.
    Thorax. 2023 Jul 20:thorax-2022-219859. doi: 10.1136/thorax-2022-219859.
    PubMed    


  55. HO T, Shahzad A, Jones A, Raghavan N, et al
    Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus.
    Thorax. 2023 Jul 9:thorax-2022-219957. doi: 10.1136/thorax-2022-219957.
    PubMed     Abstract available


  56. DE MATTEIS S
    Respiratory effects of air pollution: time to stop this deadly trajectory.
    Thorax. 2023;78:635-636.
    PubMed    


  57. SHAPANIS A, Jones MG, Schofield J, Skipp P, et al
    Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosis.
    Thorax. 2023;78:682-689.
    PubMed     Abstract available


  58. WANG X, Chen L, Cai M, Tian F, et al
    Air pollution associated with incidence and progression trajectory of chronic lung diseases: a population-based cohort study.
    Thorax. 2023;78:698-705.
    PubMed     Abstract available


  59. YOUNG RP, Ward RC, Scott RJ, Gamble GD, et al
    Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
    Thorax. 2023;78:690-697.
    PubMed     Abstract available


    June 2023
  60. PEDERSEN ES, Kuehni CE
    Heat-related hospitalisations for asthma - challenges for research.
    Thorax. 2023 Jun 28:thorax-2023-220326. doi: 10.1136/thorax-2023-220326.
    PubMed    


  61. MEME H, Amukoye E, Bowyer C, Chakaya J, et al
    Asthma symptoms, spirometry and air pollution exposure in schoolchildren in an informal settlement and an affluent area of Nairobi, Kenya.
    Thorax. 2023 Jun 6:thorax-2023-220057. doi: 10.1136/thorax-2023-220057.
    PubMed     Abstract available


  62. ANGELINI ED, Yang J, Balte PP, Hoffman EA, et al
    Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans.
    Thorax. 2023 Jun 2:thoraxjnl-2022-219158. doi: 10.1136/thorax-2022-219158.
    PubMed     Abstract available


  63. HALPIN DM
    Do the 'missing millions' of COPD patients want to be found?
    Thorax. 2023;78:531-532.
    PubMed    


  64. THUDIUM RF, Ronit A, Afzal S, Colak Y, et al
    Faster lung function decline in people living with HIV despite adequate treatment: a longitudinal matched cohort study.
    Thorax. 2023;78:535-542.
    PubMed     Abstract available


  65. NJOKU CM, Hurst JR, Kinsman L, Balogun S, et al
    COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes-a systematic review and meta-analysis.
    Thorax. 2023;78:596-605.
    PubMed     Abstract available


    May 2023
  66. MURPHY PB, Brueggenjuergen B, Reinhold T, Gu Q, et al
    Cost-effectiveness of home non-invasive ventilation in patients with persistent hypercapnia after an acute exacerbation of COPD in the UK.
    Thorax. 2023;78:523-525.
    PubMed     Abstract available


  67. MUISER S, Imkamp K, Seigers D, Halbersma NJ, et al
    Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD.
    Thorax. 2023;78:451-458.
    PubMed     Abstract available


  68. GUYATT A, John C, Williams AT, Shrine N, et al
    Mendelian randomisation of eosinophils and other cell types in relation to lung function and disease.
    Thorax. 2023;78:496-503.
    PubMed     Abstract available


  69. SPIELMANNS M, Gloeckl R, Jarosch I, Leitl D, et al
    Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial.
    Thorax. 2023;78:442-450.
    PubMed     Abstract available


    April 2023
  70. KONSTANTINOUDIS G, Minelli C, Lam HCY, Fuertes E, et al
    Asthma hospitalisations and heat exposure in England: a case-crossover study during 2002-2019.
    Thorax. 2023 Apr 17:thorax-2022-219901. doi: 10.1136/thorax-2022-219901.
    PubMed     Abstract available


  71. FAIZ A, Pavlidis S, Kuo CH, Rowe A, et al
    Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD.
    Thorax. 2023;78:335-343.
    PubMed     Abstract available


  72. HIGHAM A, Singh D
    Inhaled corticosteroid responses in COPD: do mast cells hold the answer?
    Thorax. 2023;78:323-324.
    PubMed    


  73. LI X, Lai Y, Lane Z, Strollo H, et al
    Cigarette smoking is a secondary cause of folliculin loss.
    Thorax. 2023;78:402-408.
    PubMed     Abstract available


  74. SCHNEEBERGER T, Jarosch I, Leitl D, Gloeckl R, et al
    Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial.
    Thorax. 2023;78:326-334.
    PubMed     Abstract available


    March 2023
  75. BRADLEY C, Boland A, Clarke L, Dallinson N, et al
    Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme.
    Thorax. 2023 Mar 27:thorax-2022-219683. doi: 10.1136/thorax-2022-219683.
    PubMed     Abstract available


  76. SCOTT HA, Ng SH, McLoughlin RF, Valkenborghs SR, et al
    Effect of obesity on airway and systemic inflammation in adults with asthma: a systematic review and meta-analysis.
    Thorax. 2023 Mar 22:thoraxjnl-2022-219268. doi: 10.1136/thorax-2022-219268.
    PubMed     Abstract available


  77. RAMSAHAI JM, Simpson JL, Cook A, Gibson PG, et al
    Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma.
    Thorax. 2023 Mar 22:thoraxjnl-2021-217865. doi: 10.1136/thorax-2021-217865.
    PubMed     Abstract available


  78. RUPAREL M
    Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful?
    Thorax. 2023 Mar 21:thorax-2022-219778. doi: 10.1136/thorax-2022-219778.
    PubMed    


  79. BEASLEY R, Bruce P, Hatter L
    ICS/formoterol maintenance and reliever therapy: how far beyond asthma?
    Thorax. 2023 Mar 2:thorax-2022-219979. doi: 10.1136/thorax-2022-219979.
    PubMed    


  80. MCDONALD MN
    Inventing the wheel: understanding heterogeneity of response to skeletal muscle dysfunction interventions in women with COPD.
    Thorax. 2023;78:219.
    PubMed    


  81. MOHAN D, Rossiter H, Watz H, Fogarty C, et al
    Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial.
    Thorax. 2023;78:258-266.
    PubMed     Abstract available


  82. XING Z, Sun T, Janssens JP, Chai D, et al
    Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey.
    Thorax. 2023;78:274-280.
    PubMed     Abstract available


    February 2023
  83. LEWIS A, Osadnik CR
    Changing practice by changing pressures: a role for oscillating positive expiratory pressure in chronic obstructive pulmonary disease.
    Thorax. 2023;78:113-115.
    PubMed    


  84. ALGHAMDI SM, Alsulayyim AS, Alasmari AM, Philip KEJ, et al
    Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial.
    Thorax. 2023;78:136-143.
    PubMed     Abstract available


  85. COUSINS M, Hart K, Kotecha SJ, Henderson AJ, et al
    Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity-associated lung disease.
    Thorax. 2023 Feb 1:thoraxjnl-2022-219301. doi: 10.1136/thorax-2022-219301.
    PubMed     Abstract available


    January 2023
  86. KIVISTO JE, Protudjer JLP, Karjalainen J, Bergstrom A, et al
    Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020.
    Thorax. 2023 Jan 2:thorax-2022-219539. doi: 10.1136/thorax-2022-219539.
    PubMed     Abstract available


  87. SINGH S, Moore LSP, Mughal N, Ho M, et al
    Novel inhaled antifungal for pseudomembranous Aspergillus tracheobronchitis complicating connective tissue disease.
    Thorax. 2023;78:110-111.
    PubMed    


  88. ZHANG T, Zhou R, Wang T, Xin Y, et al
    Effects of traditional mind-body movement therapy on chronic cardiopulmonary dyspnoea: a systematic review and meta-analysis.
    Thorax. 2023;78:69-75.
    PubMed     Abstract available


  89. ISLAM JY, Hoppin J, Mora AM, Soto-Martinez ME, et al
    Respiratory and allergic outcomes among 5-year-old children exposed to pesticides.
    Thorax. 2023;78:41-49.
    PubMed     Abstract available


    December 2022
  90. HEATLEY H, Tran TN, Bourdin A, Menzies-Gow A, et al
    Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma.
    Thorax. 2022 Dec 27:thorax-2022-219642. doi: 10.1136/thorax-2022-219642.
    PubMed     Abstract available


  91. IBRAHIM B, Achour D, Zerimech F, de Nadai P, et al
    Plasma thymic stromal lymphopoietin (TSLP) in adults with non-severe asthma: the EGEA study.
    Thorax. 2022 Dec 14:thoraxjnl-2022-219192. doi: 10.1136/thorax-2022-219192.
    PubMed     Abstract available


    November 2022
  92. TYDEMAN F, Pfeffer PE, Vivaldi G, Holt H, et al
    Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).
    Thorax. 2022 Nov 23:thorax-2022-219591. doi: 10.1136/thorax-2022-219591.
    PubMed     Abstract available


  93. GAUTAM Y, Mersha TB
    Leveraging genetic ancestry to study severe asthma exacerbations in an admixed population.
    Thorax. 2022 Nov 18. pii: thorax-2022-219459. doi: 10.1136/thorax-2022-219459.
    PubMed    


  94. WORGALL S
    Environmental exposures: another effect on sphingolipids in asthma?
    Thorax. 2022 Nov 11. pii: thorax-2022-219479. doi: 10.1136/thorax-2022-219479.
    PubMed    


  95. ALLAM VSRR, Pavlidis S, Liu G, Kermani NZ, et al
    Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma.
    Thorax. 2022 Nov 7. pii: thorax-2021-218555. doi: 10.1136/thorax-2021-218555.
    PubMed     Abstract available


  96. KONSTANTINOUDIS G, Minelli C, Vicedo-Cabrera AM, Ballester J, et al
    Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007-2018.
    Thorax. 2022;77:1098-1104.
    PubMed     Abstract available


  97. DA SILVA SENA CR, de Queiroz Andrade E, de Gouveia Belinelo P, Percival E, et al
    Higher exhaled nitric oxide at 6 weeks of age is associated with less bronchiolitis and wheeze in the first 12 months of age.
    Thorax. 2022;77:1106-1112.
    PubMed     Abstract available


  98. MEGHJI J, Mortimer K, Mpangama S
    TB and COPD in low-income settings: a collision of old foes.
    Thorax. 2022;77:1057-1058.
    PubMed    


  99. KAMENAR K, Hossen S, Gupte AN, Siddharthan T, et al
    Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies.
    Thorax. 2022;77:1088-1097.
    PubMed     Abstract available


  100. AHMADIAN S, Sin DD, Lynd L, Harrison M, et al
    Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease.
    Thorax. 2022;77:1079-1087.
    PubMed     Abstract available


    September 2022
  101. HERRERA-LUIS E, Mak ACY, Perez-Garcia J, Martin-Gonzalez E, et al
    Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth.
    Thorax. 2022 Sep 30. pii: thorax-2022-218755. doi: 10.1136/thorax-2022-218755.
    PubMed     Abstract available


  102. HALL I, Walker S, Holgate ST
    Respiratory research in the UK: investing for the next 10 years.
    Thorax. 2022;77:851-853.
    PubMed    


    August 2022
  103. CARRARO S, Ferraro VA, Zanconato S
    From bronchiolitis endotyping to asthma risk assessment.
    Thorax. 2022 Aug 19. pii: thorax-2022-219388. doi: 10.1136/thorax-2022-219388.
    PubMed    


  104. SOREMEKUN S, Heaney LG, Skinner D, Bulathsinhala L, et al
    Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study.
    Thorax. 2022 Aug 3. pii: thorax-2021-217032. doi: 10.1136/thorax-2021-217032.
    PubMed     Abstract available


  105. KUNOE A, Sevelsted A, Chawes BLK, Stokholm J, et al
    Height and bone mineral content after inhaled corticosteroid use in the first 6 years of life.
    Thorax. 2022;77:745-751.
    PubMed     Abstract available


  106. BURNS KEA, Stevenson J, Laird M, Adhikari NKJ, et al
    Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis.
    Thorax. 2022;77:752-761.
    PubMed     Abstract available


  107. KIM N, Kwak G, Rodriguez J, Livraghi-Butrico A, et al
    Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.
    Thorax. 2022;77:812-820.
    PubMed     Abstract available


    July 2022
  108. CRUMP C, Sundquist J, Sundquist K
    Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study.
    Thorax. 2022 Jul 30. pii: thorax-2022-218931. doi: 10.1136/thorax-2022-218931.
    PubMed     Abstract available


  109. FUJIOGI M, Zhu Z, Raita Y, Ooka T, et al
    Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Thorax. 2022 Jul 30. pii: thorax-2022-219016. doi: 10.1136/thorax-2022-219016.
    PubMed     Abstract available


  110. KEARNS N, Williams M, Bruce P, Black M, et al
    Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial.
    Thorax. 2022 Jul 18. pii: thorax-2022-219052. doi: 10.1136/thorax-2022-219052.
    PubMed     Abstract available


  111. FARNE H, Lin L, Jackson DJ, Rattray M, et al
    In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection.
    Thorax. 2022 Jul 5. pii: thoraxjnl-2021-217389.
    PubMed     Abstract available


  112. D'CRUZ RF, Kaltsakas G
    Does impaired respiratory function lead to sudden cardiac death?
    Thorax. 2022;77:641-642.
    PubMed    


  113. NICI L
    Improving the lives of individuals with chronic respiratory disease: the need for innovation.
    Thorax. 2022;77:636-637.
    PubMed    


  114. DAYNES E, Greening N, Singh SJ
    Randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea (TIDe) in COPD.
    Thorax. 2022;77:690-696.
    PubMed     Abstract available


  115. COX NS, McDonald CF, Mahal A, Alison JA, et al
    Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial.
    Thorax. 2022;77:643-651.
    PubMed     Abstract available


  116. CHENG YJ, Chen ZG, Yao FJ, Liu LJ, et al
    Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study.
    Thorax. 2022;77:652-662.
    PubMed     Abstract available


    June 2022
  117. SHIMA H, Tanabe N, Oguma A, Shimizu K, et al
    Subtyping emphysematous COPD by respiratory volume change distributions on CT.
    Thorax. 2022 Jun 29. pii: thoraxjnl-2021-218288.
    PubMed     Abstract available


  118. NAIR AA, Rv L, Christopher DJ
    'Pulmonary tuberculosis presenting as massive spontaneous pneumomediastinum and subcutaneous emphysema'.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2022-218908.
    PubMed    


  119. WU CC, Wang CC, Chung WY, Sheu CC, et al
    Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2021-218396.
    PubMed     Abstract available


  120. PASCHALAKI K, Rossios C, Pericleous C, MacLeod M, et al
    Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD.
    Thorax. 2022;77:616-620.
    PubMed     Abstract available


  121. JANSON C
    Inhaled corticosteroids in COPD: risk and benefits.
    Thorax. 2022;77:530-531.
    PubMed    


  122. EKLOF J, Ingebrigtsen TS, Sorensen R, Saeed MI, et al
    Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease.
    Thorax. 2022;77:573-580.
    PubMed     Abstract available


    May 2022
  123. WANG AL, Lahousse L, Dahlin A, Edris A, et al
    Novel genetic variants associated with inhaled corticosteroid treatment response in older adults with asthma.
    Thorax. 2022 May 2. pii: thoraxjnl-2021-217674.
    PubMed     Abstract available


    April 2022
  124. MOITRA S, Carsin AE, Abramson MJ, Accordini S, et al
    Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS.
    Thorax. 2022 Apr 27. pii: thoraxjnl-2021-217867.
    PubMed     Abstract available


  125. ANNANGI S, Nutalapati S, Sturgill J, Flenaugh E, et al
    Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease.
    Thorax. 2022;77:351-356.
    PubMed     Abstract available


    March 2022
  126. DOLBY T, Nafilyan V, Morgan A, Kallis C, et al
    Relationship between asthma and severe COVID-19: a national cohort study.
    Thorax. 2022 Mar 30. pii: thoraxjnl-2021-218629.
    PubMed     Abstract available


  127. BARBER CM, Cullinan P, Feary J, Fishwick D, et al
    British Thoracic Society Clinical Statement on occupational asthma.
    Thorax. 2022 Mar 21. pii: thoraxjnl-2021-218597.
    PubMed    


  128. GYSENS F, Mestdagh P, de Bony de Lavergne E, Maes T, et al
    Unlocking the secrets of long non-coding RNAs in asthma.
    Thorax. 2022 Mar 4. pii: thoraxjnl-2021-218359.
    PubMed     Abstract available


  129. STANDL M
    Limited side effects of asthma treatment on growth and bone health in children.
    Thorax. 2022 Mar 4. pii: thoraxjnl-2021-218531.
    PubMed    


  130. KEIRSBULCK M, Savoure M, Lequy E, Chen J, et al
    Long-term exposure to ambient air pollution and asthma symptom score in the CONSTANCES cohort.
    Thorax. 2022 Mar 2. pii: thoraxjnl-2021-218344.
    PubMed     Abstract available



  131. Correction: Association of asthma severity and educational attainment at age 6-7 years in a birth cohort: population-based record-linkage study.
    Thorax. 2022;77:e2.
    PubMed    


  132. STONE PW, Adamson A, Hurst JR, Roberts CM, et al
    Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
    Thorax. 2022;77:239-246.
    PubMed     Abstract available


  133. CHENG SWM, Alison J, Stamatakis E, Dennis S, et al
    Six-week behaviour change intervention to reduce sedentary behaviour in people with chronic obstructive pulmonary disease: a randomised controlled trial.
    Thorax. 2022;77:231-238.
    PubMed     Abstract available


    February 2022
  134. WOODCOCK A, Janson C, Rees J, Frith L, et al
    Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis.
    Thorax. 2022 Feb 7. pii: thoraxjnl-2021-218088.
    PubMed     Abstract available


  135. GHOSH AJ, Saferali A, Lee S, Chase R, et al
    Blood RNA sequencing shows overlapping gene expression across COPD phenotype domains.
    Thorax. 2022;77:115-122.
    PubMed     Abstract available


  136. EKSTROM M, Johannessen A, Abramson MJ, Benediktsdottir B, et al
    Breathlessness across generations: results from the RHINESSA generation study.
    Thorax. 2022;77:172-177.
    PubMed     Abstract available


    January 2022
  137. HOPKINSON NS, Lenney W, Langton-Hewer S, Bennett J, et al
    Children's charter for lung health.
    Thorax. 2022;77:11-12.
    PubMed    


  138. BECKER EJ, Faiz A, van den Berge M, Timens W, et al
    Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD.
    Thorax. 2022;77:31-39.
    PubMed     Abstract available


    December 2021
  139. NIELSEN MB, Nordestgaard BG, Benn M, Colak Y, et al
    Plasma adiponectin and risk of asthma: observational analysis, genetic Mendelian randomisation and meta-analysis.
    Thorax. 2021 Dec 23. pii: thoraxjnl-2021-217675.
    PubMed     Abstract available


  140. FOO CT, Karia S, Herre J
    Reversible bronchiectasis.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217548.
    PubMed    


  141. O'BRIEN ME, Zou RH, Hyre N, Leader JK, et al
    CT pectoralis muscle area is associated with DXA lean mass and correlates with emphysema progression in a tobacco-exposed cohort.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217710.
    PubMed     Abstract available


  142. AMARAL AFS, Burney PGJ, Patel J, Minelli C, et al
    Chronic airflow obstruction and ambient particulate air pollution.
    Thorax. 2021;76:1236-1241.
    PubMed     Abstract available


    November 2021
  143. LEE JH, Kim TB
    Eosinophil granule proteins: what they can tell us about asthma.
    Thorax. 2021 Nov 26. pii: thoraxjnl-2021-218268.
    PubMed    


  144. BEDI P, Ziegler K, Whitfield PD, Davidson D, et al
    Dysregulation of prostaglandins, leukotrienes and lipoxin A4 in bronchiectasis.
    Thorax. 2021 Nov 17. pii: thoraxjnl-2020-216475.
    PubMed     Abstract available


  145. STEWART I, Bloom CI
    Considerations for conducting and interpreting long-term follow-up of intervention studies: avoiding spoiled milk.
    Thorax. 2021;76:1067-1068.
    PubMed    


  146. POLOSUKHIN VV, Gutor SS, Du RH, Richmond BW, et al
    Small airway determinants of airflow limitation in chronic obstructive pulmonary disease.
    Thorax. 2021;76:1079-1088.
    PubMed     Abstract available


    October 2021
  147. FARNE H, Glanville N, Johnson N, Kebadze T, et al
    Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial.
    Thorax. 2021 Oct 29. pii: thoraxjnl-2021-217429.
    PubMed     Abstract available


  148. CREESE H, Lai E, Mason K, Schluter DK, et al
    Disadvantage in early-life and persistent asthma in adolescents: a UK cohort study.
    Thorax. 2021 Oct 14. pii: thoraxjnl-2021-217312.
    PubMed     Abstract available


  149. GRANGER V, Zerimech F, Arab J, Siroux V, et al
    Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults.
    Thorax. 2021 Oct 6. pii: thoraxjnl-2021-217343.
    PubMed     Abstract available


    September 2021
  150. BAGGOTT C, Hardy JK, Sparks J, Sabbagh D, et al
    Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis.
    Thorax. 2021 Sep 30. pii: thoraxjnl-2021-217124.
    PubMed     Abstract available


  151. KHO AT, McGeachie MJ, Li J, Chase RP, et al
    Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma.
    Thorax. 2021 Sep 27. pii: thoraxjnl-2020-215523.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.